Explain this page
Arphra AIPlain-English read on Vertex Pharmaceuticals Incorporated’s valuationCompany profile
DB · companies + sec_company_profile + company_profilesVertex Pharmaceuticals Incorporated (VRTX) — the SEC company profile (description, website, HQ) has not been loaded for this ticker yet. Run the SEC profile loader to populate it.
AI description
Arphra AILoading cached description…
Identifiers
- SymbolVRTX
- Legal nameVertex Pharmaceuticals Incorporated
- CEO—
- SectorHealthcare
- IndustryBiotechnology
- CountryUS
- CurrencyUSD
- ExchangeNASDAQ
- IPO date—
- CIK0000875320
- ISIN—
- CUSIP—
- LEI—
- Employees—
Trading
DB · key_metrics_ttmMay 02, 2026- Market cap$107.83B
- P/E (TTM)—
- P/B—
- EV / EBITDA—
- Dividend yield—
Identifiers
OpenFIGI · GLEIFCross-source keys used to bridge market-data, SEC, and non-US sources.
- FIGIBBG000C1S2X2
- CountryUS
Key executives
DB · executives| Name | Title | Compensation | Born | Since |
|---|---|---|---|---|
| Reshma Kewalramani FASN | Chief Executive Officer, President & Director | $6.14M | 1973 | — |
| Charles F. Wagner Jr. | Executive Vice President, Chief Operating Officer & Chief Financial Officer | $2.99M | 1968 | — |
| David Altshuler | Executive Officer | $2.39M | 1965 | — |
| Mark Bunnage D.Phil | Executive Vice President & Chief Scientific Officer | $2.39M | 1969 | — |
| Carmen Bozic | Executive VP of Global Medicines Development & Medical Affairs and Chief Medical Officer | $2.27M | 1963 | — |
| Ourania Tatsis | Executive Vice President and Chief Regulatory & Quality Officer | $2.07M | 1970 | — |
| Amit K. Sachdev | Executive Vice President & Chief Patient and External Affairs Officer | $1.88M | 1968 | — |
| Kristen C. Ambrose | Senior Vice President & Chief Accounting Officer | — | 1977 | — |